Evidence map›Paper›PMID 30393376›Full record

ReviewGenetics in medicine : official journal of the American College of Medical Genetics2019

Foundation of the Newborn Screening Translational Research Network and its tools for research.

Michele Lloyd-Puryear, Amy Brower, Susan A Berry, Jeffrey P Brosco, Bruce Bowdish, Michael S Watson

Abstract readReview
PubMed Publisher
In one paragraph

Review in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The Progress and Future of US Newborn Screening.International journal of neonatal screening · 2022
    Review
  7. Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Human Phenotype Ontology in 2021.Nucleic acids research · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michele Lloyd-PuryearAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA.
Amy BrowerAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA.
Susan A BerryDepartments of Pediatrics and Genetics, University of Minnesota, St. Paul, MN, USA.
Jeffrey P BroscoDepartment of Pediatrics, University of Miami, Miami, FL, USA.
Bruce BowdishAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA.
Michael S WatsonAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA. mwatson@acmg.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past 20 years, several policy activities were undertaken that shaped today's newborn screening (NBS) programs and their associated NBS research activities: the Newborn Screening Task Force Report; the Child Health Act of 2000, Screening for Heritable Disorders; the American College of Medical Genetics and Genomics' (ACMG's) Newborn Screening Uniform Panel; and the ACMG expert panel to examine the development of a national collaborative study system for rare genetic diseases. These activities helped conceptualize the Newborn Screening Translational Research Network (NBSTRN) infrastructure and lay the foundation for its current activities. After 10 years, NBSTRN has grown into an organization that provides tools and resources for researchers to conduct research relevant to NBS programs for rare diseases for which data has been siloed locally. Infrastructure includes tools for the analytical and clinical validation of screening tests; the collection, analysis, sharing, and reporting of longitudinal laboratory and clinical data on newborn-screened individuals; and a web-based tool that allows researchers to acquire dried blood spots available for use in research from state NBS programs. NBSTRN also provides tools for researchers such as informed consent templates, disease registries, state NBS profiles, and consultation on planning pilot studies. In time, the growing data will become a resource itself.

Indexed as

FemaleHumansInfant, NewbornMaleNeonatal ScreeningRare DiseasesTranslational Research, BiomedicalUnited Statesgeneticsgenomicsnewborn screeningpublic healthtranslational research

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.